Don't Miss The World's #1 Executive Networking Event"
Home ⟩ Insights
Insights
analyst-color
2 min read • February 7, 2020
Aurora Cannabis Analyst Welcomes Restructuring, But Sales Trends Are ‘Disappointing’
1 min read • February 7, 2020
UPDATE: Cantor Fitzgerald Maintains Overweight On Aurora Cannabis, Lowers Target To C$3.75 As Firm Thinks Co’s ‘Restructuring is Good News’ ‘But sales trends for Dec and March are disappointing’
2 min read • February 4, 2020
Illinois Recreational Cannabis Sales Reach Nearly $40M In January, Analyst Expects ‘Domino Effect’
2 min read • February 4, 2020
BofA Sees Blockbuster Sales Potential For GW Pharma’s CBD Drug Epidiolex
2 min read • January 28, 2020
4 Reasons To Buy Aurora Cannabis Stock
2 min read • January 23, 2020
Analyst Raises Price Objectives For Cannabis Stocks: ‘Higher Multiples Raise The Bar For All’
2 min read • January 22, 2020
Analyst Dives Into Cannabis 2.0, Says There Are Fewer Suppliers And A More Concentrated Market
2 min read • January 21, 2020
Analyst: Cannabis Companies Cautious About The First Half Of 2020
2 min read • January 16, 2020
GW Pharma Analyst Expects $475M In Sales Of CBD Drug Expidiolex This Year
1 min read • January 16, 2020
420 Investor Alan Brochstein, When Asked About Strength In Cannabis Stocks, Tells Benzinga ‘The Organigram report triggered a stampede. I would argue that the way the market shook off “disappointing” results from Aphria the day before was a factor too.’
2 min read • January 14, 2020
Aphria’s Q2 Cannabis Sales Exceed Cantor Fitzgerald’s Expectations
2 min read • January 13, 2020
Cantor Fitzgerald On Aurora Cannabis: Buy The Dip
Latest Headlines
View All
6 min read • June 3, 2026
The Celebrity Cannabis Boom Became A Graveyard. The Survivors Had Four Things In Common
2 min read • June 2, 2026
Vireo Growth Reshapes Share Structure After Major Expansion Transactions
2 min read • June 2, 2026
Cannabis Giant, Verano, Joins Industry Peers In Reverse Stock Split Trend With 1-For-5 Consolidation
7 min read • June 2, 2026
Cannabis M&A Is Back, But Not The Way Investors Expected
4 min read • June 2, 2026
EXCLUSIVE: Virginia Governor Defends Cannabis Veto, Citing Timeline And Licensing Concerns
2 min read • June 1, 2026
Five-Month Hemp Enforcement Grace Period Ends In Oregon, Here’s What Businesses Must Know
3 min read • June 1, 2026
New Tennessee Hemp Rules Threaten THCa Market And Millions Of Dollars In Sales
3 min read • June 1, 2026
Robinhood Opens The Door To U.S. Cannabis Stocks
4 min read • June 1, 2026
Fireman Entrepreneur Award Builds Momentum Ahead of 2026 Announcement in Chicago
4 min read • June 1, 2026
Thin Legal Challenge from State AGs Could Still Complicate Federal Cannabis Rescheduling Effort
2 min read • May 29, 2026
Canopy Growth Bets On Europe As It Relaunches This Legacy Brand in Germany’s $1B Medical Cannabis Market
2 min read • May 29, 2026
Minnesota’s New Cannabis Bill Reshapes Market For Medical And Rec Operators
Browse By Channels
After-Hours Center
Analyst Color
Analyst Ratings
Andy Barr
Asia
Asset Sales
Be Your Own Boss
Binary Options
Biotech
Bonds
Broad U.S. Equity ETFs
Buybacks
california cannabis
Cannabis
cannabis earnings
cannabis farms
cannabis study
Christopher Dillis
CNBC
Commodities
Congress cannabis
Congress hemp
Contracts
Crowdsourcing
Cryptocurrency
Currency ETFs
Dividends
Downgrades
Earnings
Earnings Beats
Earnings Misses
Econ #s
Economics
Education
Emerging Market ETFs
Emerging Markets
Entertainment
Entrepreneurship
Equities
ESG
ETFs
Eurozone
Events
Exclusives
Fast Money
FDA
Federal Reserve
Financial Advisors
Financing
Fintech
first quarter earnings
Forex
Futures
Gaming
General
Global
Government
Guidance
Health Care
Hedge Funds
hemp bill
hemp legalization
hemp regulation
Hot
illegal cannabis farms
Initiation
Insider Trades
Insurance
Interview
intoxicating hemp-derived products
Intraday Update
IPOs
James Comer
Large Cap
Latin America
Legal
Long Ideas
M&A
Macro Economic Events
Macro Notification
Management
marijuana
Market Summary
Market-Moving Exclusives
Markets
Media
Mid Cap
Movers
Movers & Shakers
New ETFs
News
Offerings
Opinion
Options
Penny Stocks
Personal Finance
Politics
Pre-Market Outlook
Press Releases
Previews
Price Target
Psychedelics
Psychology
Real Estate
Regulations
REIT
Reiteration
Rescheduling
Restaurants
Retail Sales
Reviews
Rumors
SEC
Sector ETFs
Short Ideas
Short Sellers
Signals
Small Business
Small Cap
Small Cap Analysis
Social Media
Specialty ETFs
Sports
Sports Betting
Startups
Stock Split
Success Stories
Taxes
Tech
Technicals
THC
Top Stories
Topics
Trading Ideas
Travel
UC Berkeley Cannabis Research Center
unlicensed cannabis
Upgrades
WIIM
Join the Cannabis Revolution
Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.